Morris Plains, NJ, United States of America

Martin Lawrence Schwartz

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Martin Lawrence Schwartz: Innovator in Pharmaceutical Chemistry

Introduction

Martin Lawrence Schwartz is a notable inventor based in Morris Plains, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on innovative processes that enhance the synthesis of pharmaceutical compounds.

Latest Patents

Among his latest patents, Schwartz has developed a method for the stereoselective alkylation of chiral 2-methyl-4-protected piperazines. This invention describes a novel stereoselective alkylation process that results in high stereochemical purity of the synthesized compounds. Additionally, he has patented a process for the preparation of pharmaceutical salts, which allows for the direct preparation of an unequal ratio of rotamers of an acid salt from a basic compound. This process is particularly beneficial in creating specific rotamers of pharmaceutically useful salts in desired preponderance.

Career Highlights

Schwartz is currently associated with Schering Corporation, where he applies his expertise in pharmaceutical chemistry. His innovative approaches have contributed to advancements in drug development and synthesis.

Collaborations

Some of his notable coworkers include Dinesh Gala and Gary M Lee, who collaborate with him on various projects within the pharmaceutical sector.

Conclusion

Martin Lawrence Schwartz is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to improving drug synthesis processes, making a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…